2025-07-05 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the provided data. The report is written in English, includes key figures, and provides a brief analysis of each section, followed by a comprehensive summary.

**Report: UnitedHealth Group Inc (UNH) Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** UNH
*   **Company:** UnitedHealth Group Inc
*   **Description:** A diversified health care company offering a wide range of products and services.
*   **UNH Cumulative Return:** 22.37%
*   **VOO Cumulative Return:** 95.42%
*   **Deviation:**
    *   **Current:** -72.06% (UNH is lagging S&P 500)
    *   **Range:** Max: 55.3%, Min: -72.3%
    *   **Relative Deviation:** 0.2 (Indicates the current deviation is near the minimum end of its historical range)

**Analysis of Alpha, Beta, CAGR, MDD (2015-2025)**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B)  |
|------------|---------|---------|---------|--------|---------|
| 2015-2017  | 65.0%   | 56.6%   | 36.0%   | 0.0    | 200.0   |
| 2016-2018  | 52.0%   | 63.7%   | 34.0%   | 0.0    | 226.0   |
| 2017-2019  | 38.0%   | 63.7%   | 9.0%    | 0.3    | 266.7   |
| 2018-2020  | -21.0%  | 63.7%   | -40.0%  | 0.4    | 318.1   |
| 2019-2021  | 36.0%   | 61.0%   | -13.0%  | 0.4    | 455.5   |
| 2020-2022  | 28.0%   | 66.9%   | 26.0%   | 0.4    | 480.9   |
| 2021-2023  | 33.0%   | 67.5%   | 15.0%   | 0.4    | 477.6   |
| 2022-2024  | -31.0%  | 68.6%   | -57.0%  | 0.3    | 458.9   |
| 2023-2025  | -54.0%  | 75.7%   | -101.0% | 0.2    | 279.9   |

**Analysis:**

*   **Underperformance:** UNH has significantly underperformed the S&P 500, with a substantial negative deviation. The Relative Deviation suggests this underperformance is near its historical worst.
*   **Alpha/Beta Trends:** The Alpha values are largely negative in the later periods, indicating UNH is underperforming relative to its risk-adjusted expected return. Beta values are relatively low, meaning UNH is less sensitive to market movements.
*   **CAGR and MDD:** The recent period (2023-2025) shows a significant negative CAGR with a high MDD, indicating substantial losses and high volatility. The earlier years (2015-2019) generally showed strong positive growth.

**2. Recent Price Action**

*   **Current Price:** $308.55
*   **Previous Close:** $307.56
*   **Change:** 0.32%
*   **5-day Moving Average:** 313.35
*   **20-day Moving Average:** 307.60
*   **60-day Moving Average:** 366.75

**Analysis:**

*   **Slight Gain:** The price has slightly increased compared to the previous close.
*   **Moving Averages:** The price is below the 5-day moving average (short-term downtrend), hovering above the 20-day moving average (medium-term consolidation), and significantly below the 60-day moving average (longer-term downtrend). This suggests a possible medium-term consolidation phase after a longer-term decline.

**3. Market Risk Indicators & Expected Return**

*   **MRI:** 0.33 (Low Risk)
*   **RSI:** 42.94 (Neutral, not overbought or oversold)
*   **PPO:** 1.23 (Price Oscillator above zero, indicating bullish momentum)
*   **Hybrid Signal:**  cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** 0.2 (+) (Short-term upward trend)
*   **Expected Return:** 1247.7% (Long-term expected outperformance vs. S&P 500)

**Analysis:**

*   **MRI:** A low MRI suggests the overall market risk is low, which could be a positive factor.
*   **RSI:** The neutral RSI indicates no strong momentum in either direction.
*   **PPO:** The positive PPO suggests short-term bullish momentum.
*   **Delta_Previous_Relative_Divergence:** The positive change suggests the relative performance against the S&P 500 is improving in the short term.
*   **Expected Return:** The extremely high expected return should be viewed with caution. It is a projection based on a specific model and may not be realistic.

**4. Recent News & Significant Events**

*   **[2025-07-02]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-05]:** Analysts discussing performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-04]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-03]:** Market experts highlight both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**

*   **Key Takeaway:** Recent news indicates volatility and uncertainty surrounding UNH. Investors should closely monitor company announcements, analyst reports, and industry news.

**5. Recent Earnings Analysis**

| 날짜         | EPS    | 매출           |
|--------------|--------|----------------|
| 2025-05-07   | 6.90   | 109.58 B$     |
| 2024-11-04   | 6.56   | 100.82 B$     |
| 2024-08-09   | 4.58   | 98.86 B$      |
| 2024-05-09   | -1.53  | 99.80 B$      |
| 2025-05-07   | -1.53  | 99.80 B$      |

**Analysis:**

*   **Mixed Performance:** The earnings data shows a mix of positive and negative EPS figures.
*   **Revenue Growth:** Revenue has generally been increasing over the periods, but the most recent quarter shows a significant increase.
*   **Inconsistency in EPS:** The negative EPS in some quarters is a cause for concern and needs further investigation to understand the underlying reasons.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $109.58B  | 21.70%        |
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |
| 2024-03-31 | $99.80B   | 23.05%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2025-03-31 | $95.04B  | 6.62%   |
| 2024-12-31 | $92.66B  | 5.98%   |
| 2024-09-30 | $94.53B  | 6.41%   |
| 2024-06-30 | $89.36B   | 4.72%   |
| 2024-03-31 | $86.69B   | -1.63%  |

**Analysis:**

*   **Revenue Growth:** Consistent revenue growth is observed, with a substantial increase in the latest quarter.
*   **Stable Profit Margins:** Profit margins remain relatively stable around the 21-23% range, indicating efficient operations.
*   **Equity and ROE:** Equity has been steadily increasing, but ROE shows some fluctuation. The negative ROE in 2024-03-31 warrants further investigation.

**7. Overall Summary**

UnitedHealth Group Inc (UNH) has shown mixed performance. While revenue and profitability appear healthy, recent stock performance has significantly lagged the S&P 500.  The company is experiencing volatility, driven by recent business developments, regulatory changes, or market events.  Recent earnings have been inconsistent, with some quarters showing negative EPS. The technical indicators show a potential for short-term upward movement, but caution is advised due to the longer-term downtrend and negative Alpha. The very high expected return should be taken with a grain of salt.

**Recommendation:**

Given the current underperformance, volatility, and mixed earnings, a cautious approach is recommended. Investors should closely monitor company news, analyst reports, and industry trends before making any investment decisions. Further investigation into the reasons for the negative EPS and negative Alpha is warranted. The extremely high expected return should not be the sole basis for investment.

